Target intelligence / Profile preview

ATP-binding cassette subfamily B member 1 (ABCB1) and ATP-binding cassette subfamily G member 2 (ABCG2) (ABCB1 and ABCG2)

Target
ABCB1 and ABCG2
Molecular classification
Transporter, ABC transporter (ATP-binding cassette family)
01

Overview

ABCB1 (P-glycoprotein/MDR1) and ABCG2 (BCRP) are major human ATP-binding cassette transporters that actively pump a wide variety of substrates—including many drugs—out of cells using energy from ATP hydrolysis. They are highly expressed in tissues involved in drug absorption and excretion (intestine, liver, kidney, blood-brain barrier) and are functionally associated with multidrug resistance, especially in tumor cells. Overexpression of either protein contributes to reduced intracellular drug levels and clinical resistance to chemotherapy. These proteins are also implicated in drug-drug interactions and variability in therapeutic response due to genetic polymorphisms and differential tissue expression.

Other names
P-glycoproteinMDR1multi-drug resistance protein 1 (MDRP1)Breast cancer resistance protein (BCRP)MXRABCP
02

Mechanism of action

Efflux of drugs out of cells, lowering intracellular concentrations and efficacy. Confer resistance to chemotherapy by reducing drug accumulation in tumor cells.

03

Biological functions

Drug effluxProtection against toxinsRegulation of drug bioavailabilityChemoresistance
04

Disease associations

Cancer (especially associated with multidrug resistance in tumors)Potential roles in infection and other conditions where drug disposition is altered
05

Safety considerations

Drug resistance complicates chemotherapy and other pharmacological treatmentsPotential for drug-drug interactions due to transporter modulation by various agentsAltered drug pharmacokinetics in tissues with high transporter expression (i.e., blood-brain barrier, liver, intestine)
06

Interacting drugs

Doxorubicin

3 more in the full profile.

07

Biomarkers

Expression levels of ABCB1 and ABCG2 in tumor tissue may predict chemoresistance and patient responseSingle nucleotide polymorphisms affecting drug disposition

Beyond the preview

Go deeper on ATP-binding cassette subfamily B member 1 (ABCB1) and ATP-binding cassette subfamily G member 2 (ABCG2) (ABCB1 and ABCG2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP-binding cassette subfamily B member 1 (ABCB1) and ATP-binding cassette subfamily G member 2 (ABCG2) (ABCB1 and ABCG2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call